BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
19.73
-0.56 (-2.76%)
At close: Mar 9, 2026, 4:00 PM EDT
19.74
+0.01 (0.05%)
After-hours: Mar 9, 2026, 6:15 PM EDT
BioAge Labs Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -75.79 | -71.11 | -63.85 | -39.72 |
| Depreciation & Amortization | 0.19 | 0.17 | 0.16 | 0.13 |
| Loss (Gain) From Sale of Assets | 0.06 | 0.06 | - | - |
| Stock-Based Compensation | 11.69 | 6.98 | 3.02 | 2.54 |
| Other Operating Activities | -0.15 | 1.21 | 16.6 | 0.08 |
| Change in Accounts Payable | 2.97 | 0.01 | -0.39 | 0.99 |
| Change in Unearned Revenue | 8.06 | 9.19 | 3.31 | - |
| Change in Other Net Operating Assets | -5.03 | 1.98 | 3.79 | -0.2 |
| Operating Cash Flow | -58.51 | -51.52 | -37.36 | -36.18 |
| Capital Expenditures | -0.63 | -0.37 | -0.17 | -0.1 |
| Investment in Securities | -80.18 | - | -0.1 | - |
| Investing Cash Flow | -80.81 | -0.37 | -0.27 | -0.1 |
| Short-Term Debt Issued | - | - | 23.5 | - |
| Long-Term Debt Issued | - | - | 12.5 | 2.5 |
| Total Debt Issued | - | - | 36 | 2.5 |
| Long-Term Debt Repaid | - | -6 | -1 | - |
| Net Debt Issued (Repaid) | -6 | -6 | 35 | 2.5 |
| Issuance of Common Stock | 27.65 | 222.25 | 0 | 0.04 |
| Other Financing Activities | -1.29 | -5.05 | -0.06 | -0.05 |
| Financing Cash Flow | 20.36 | 381.2 | 34.94 | 2.5 |
| Foreign Exchange Rate Adjustments | 0.07 | 0.08 | - | 0.25 |
| Net Cash Flow | -118.9 | 329.39 | -2.69 | -33.54 |
| Free Cash Flow | -59.15 | -51.89 | -37.53 | -36.28 |
| Free Cash Flow Per Share | -1.65 | -4.84 | -22.43 | -21.70 |
| Cash Interest Paid | 0.8 | 1.42 | 1.16 | 0.13 |
| Levered Free Cash Flow | -41.48 | -34.21 | -27.91 | - |
| Unlevered Free Cash Flow | -40.9 | -32.73 | -23.04 | - |
| Change in Working Capital | 5.49 | 11.18 | 6.71 | 0.8 |
Source: S&P Capital IQ. Standard template.
Financial Sources.